Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $2.21 on 23-01-2026 at 08:01:11
Change $0.00 0%
Buy $2.21
Sell $2.19
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 88.00 at $2.21
Day's Volume: 3,588
Last Close: $2.21
Open: $2.21
ISIN: GG00BKTRRM22
Day's Range $2.21 - $2.21
52wk Range: $1.08 - $2.32
Market Capitalisation: $721.29m
VWAP: $2.209916
Shares in Issue: 326.37m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 88 $2.21 SI Trade
 08:00:55 - 23-Jan-26
Sell* 2,277 $2.18982 SI Trade
Suspected SELL Trade
 16:47:04 - 22-Jan-26
Sell* 17,454 $2.21 Automatic Execution
 16:35:59 - 22-Jan-26
Buy* 15,000 $2.21 Automatic Execution
 16:35:47 - 22-Jan-26
Buy* 59,450 $2.21 Suspected BUY Trade
 16:35:26 - 22-Jan-26
Unknown* 302 $2.19592 Ordinary
Currency Conversion
 16:29:49 - 22-Jan-26
Sell* 4 $2.20 Automatic Execution
 16:28:44 - 22-Jan-26
Buy* 121 $2.21 SI Trade
 16:28:17 - 22-Jan-26
Buy* 3,571 $2.20 Automatic Execution
 16:12:44 - 22-Jan-26
Unknown* 50,000 $2.20 OTC Trade
 16:12:42 - 22-Jan-26
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Jan 2026 (Fri) 2.21 2.21 2.21 2.21 3,588
22nd Jan 2026 (Thu) 2.22 2.22 2.19 2.21 361,329
21st Jan 2026 (Wed) 2.16 2.23 2.15 2.21 1,058,668
20th Jan 2026 (Tue) 2.13 2.18 2.07 2.16 472,396
19th Jan 2026 (Mon) 2.13 2.16 2.11 2.15 278,395
16th Jan 2026 (Fri) 2.22 2.25 2.13 2.15 697,366
15th Jan 2026 (Thu) 2.28 2.30 2.22 2.23 522,343
14th Jan 2026 (Wed) 2.23 2.32 2.23 2.32 1,433,826
13th Jan 2026 (Tue) 2.24 2.26 2.24 2.25 775,694
12th Jan 2026 (Mon) 2.23 2.26 2.23 2.26 1,065,222
9th Jan 2026 (Fri) 2.16 2.24 2.16 2.24 362,986
8th Jan 2026 (Thu) 2.16 2.21 2.16 2.20 202,728
7th Jan 2026 (Wed) 2.16 2.19 2.16 2.16 171,672
6th Jan 2026 (Tue) 2.16 2.20 2.16 2.20 274,097
5th Jan 2026 (Mon) 2.18 2.19 2.17 2.19 342,057
2nd Jan 2026 (Fri) 2.16 2.18 2.16 2.17 367,350
1st Jan 2026 (Thu) 2.16 2.16 2.16 2.16 0
31st Dec 2025 (Wed) 2.22 2.22 2.16 2.16 47,175
30th Dec 2025 (Tue) 2.18 2.19 2.16 2.19 48,888
29th Dec 2025 (Mon) 2.21 2.21 2.18 2.19 115,245
26th Dec 2025 (Fri) 2.16 2.16 2.16 2.16 0
25th Dec 2025 (Thu) 2.16 2.16 2.16 2.16 0
24th Dec 2025 (Wed) 2.18 2.18 2.16 2.16 58,665
23rd Dec 2025 (Tue) 2.25 2.25 2.18 2.18 296,657
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
22nd Jan 2026 10:00 am RNS Director/PDMR Shareholding
21st Jan 2026 7:00 am RNS GSK to acquire RAPT Therapeutics
16th Jan 2026 7:00 am RNS Boston Scientific to acquire Penumbra
15th Jan 2026 7:00 am RNS Monthly Valuation Update and Factsheet
12th Jan 2026 7:00 am RNS Aktis announces $318 million IPO
2nd Jan 2026 7:00 am RNS Total Voting Rights
2nd Jan 2026 7:00 am RNS Total Voting Rights
18th Dec 2025 7:00 am RNS New investment in Yarrow Bioscience
12th Dec 2025 7:00 am RNS Monthly Valuation Update and Factsheet
10th Dec 2025 7:00 am RNS Transaction in Own Shares
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

IN BRIEF: RTW Biotech welcomes GSK deal to buy RAPT Therapeutics

21st Jan 2026 11:37

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Notes GSK PLC's announcement on Tuesday that it has agreed to acquire RAPT Therapeutics Inc. Says RAPT, a Californian biopharmaceutical company developing therapies for inflammatory and immunologic diseases, represented 0.15% of its net asset value as of December 31. The all-cash transaction values RAPT at USD2.2 billion, with shareholders to receive USD58 per share. RTW says the price represents a 65% premium to RAPT's closing price on Monday. Read More

RTW Biotech's portfolio firm Penumbra acquired by Boston Scientific

16th Jan 2026 09:01

(Alliance News) - RTW Biotech Opportunities Ltd on Thursday noted Boston Scientific Corp's USD14.5 billion acquisition of Penumbra Inc, a portfolio company that represented 1.0% of its net asset value at the end of 2025. Read More

LONDON BRIEFING: Next redeems B shares; Johnson Service ups guidance

16th Jan 2026 07:56

(Alliance News) - Next confirms the redemption of B shares as part of its GBP421 million capital return, Johnson Service reports resilient 2025 trading with rising earnings, and Irish Residential Properties REIT announces a CFO transition. Read More

RTW Biotech portfolio firm Aktis raises USD318 million in US IPO

12th Jan 2026 11:08

(Alliance News) - RTW Biotech Opportunities Ltd on Monday said its portfolio company Aktis Oncology Inc has completed a USD318 million IPO on New York's Nasdaq, the first biotech listing of 2026. Read More

LONDON BRIEFING: British Land CEO to leave; Heathrow posts record year

12th Jan 2026 07:59

(Alliance News) - British Land CEO Simon Carter will step down after five years in the role, as Plus500 reports revenue and Ebitda ahead of expectations and Oxford Nanopore posts stronger-than-guided full-year sales growth, while Heathrow celebrates a record 84 million passengers in 2025. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value10,149.09
Change-0.96

Login to your account

Forgot Password?

Not Registered